ARTICLE | Clinical News
Reticulose anti-viral peptide nucleic acid solution: Will start a pilot trial within a few weeks in five AZT-naive AIDS patients to assess effect on viral load
January 30, 1995 8:00 AM UTC
Advanced Viral Research Corp. (ADVR), Miami Product: Reticulose anti-viral peptide nucleic acid solution Indication: HIV infection Status: Will start a pilot trial within a few weeks in five AZT-naive...